Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy

Mol Cancer. 2022 Feb 4;21(1):36. doi: 10.1186/s12943-021-01493-6.

Authors

Yudong Liu^#¹, Xia Mao^#¹, Zhaochen Ma¹, Wenjia Chen¹, Xiaodong Guo², Lingxiang Yu², Xinxin Deng¹, Funeng Jiang¹, Taixian Li¹, Na Lin¹, Yanqiong Zhang³

Affiliations

¹ Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
² Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
³ Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. yqzhang@icmm.ac.cn.

^# Contributed equally.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Hepatocellular* / genetics
Carcinoma, Hepatocellular* / therapy
Cell Proliferation / genetics
Humans
Liver Neoplasms* / genetics
Liver Neoplasms* / therapy
MicroRNAs* / genetics
Prognosis
RNA, Long Noncoding* / genetics
RNA, Messenger / genetics

Substances

MIRN328 microRNA, human
MicroRNAs
RNA, Long Noncoding
RNA, Messenger